tbuckley/cabot-search huggingface dataset:
SAT-481-YI Improved handling of BCLC 2022 update in the management of hepatocellular carcinoma in clinical practice
Authors: Eleonora Alimenti, Massimo Iavarone, Lorenzo Canova, Mariangela Bruccoleri, Barbara Antonelli, Anna Maria Ierardi, Angelo Sangiovanni, Pietro Lampertico
Journal: Journal of Hepatology (2024)
SAT-011 Everolimus and de novo malignancies after liver transplantation in a nationwide french cohort study: an emulated target trial
Authors: Ilias Kounis, Long Nguyen, Christophe Desterke, Nathalie Goutte, Didier Samuel, Daniel Azoulay, Eric Vibert, Audrey Coilly, Paul Landais, Cyrille Feray
Journal: Journal of Hepatology (2024)
SAT-013 Sequential normothermic regional and end-ischemic ex-situ machine perfusion allows the safe use of very old DCD donors in liver transplantation (DCDNet trial)
Authors: Caterina Martinelli, Davide Ghinolfi, Daniele Pezzati, Jessica Bronzoni, Arianna Trizzino, Emanuele Balzano, Paola Carrai, Gabriele Catalano, Stefania Petruccelli, Giovanni Tincani, Simona Palladino, Davide Ghinolfi
Journal: Journal of Hepatology (2024)
SAT-532-YI Distinct soluble and cellular immunological signatures in various entities of hepatitis flares
Authors: Roni Souleiman, Erich Freyer, Tijana Ristic, Christine Falk, Benjamin Maasoumy, Heiner Wedemeyer, Bernd Heinrich, Anke R.M. Kraft, Markus Cornberg
Journal: Journal of Hepatology (2024)
SAT-158 Machine learning-driven identification of serum protein signature for primary sclerosing cholangitis and enhanced liver fibrosis score
Authors: Tom Snir, Raanan Greenman, Avi Katav, Revital Aricha, Matthew Frankel, John Lawler, Francesca Saffioti, Douglas Thorburn, Massimo Pinzani, Ilan Vaknin, Adi Mor
Journal: Journal of Hepatology (2024)
TOP-553 Deciphering the immunological dynamics of flares following nucleos (t)ide analogue (NA) cessation in HBeAg negative chronic hepatitis B in a large, longitudinal, phase II multi-centred clinical trial (NUC-B study)
Authors: Sandra Phillips, Sameer Mistry, Nicola Harris, Dimple Zope, Celia Moore, Gareth Hahn, Michelle Rosario, Camilla Carr-Smith, Maria Cortes Carrillo, Lavanya Elangovan, Kosh Agarwal, James Hand, Chris Sivell, Patrick Kennedy, Susan Congreave, Mathew Barnes, Stephen D. Ryder, Mariam Habib, Mark R. Thursz, Shilpa Chokshi
Journal: Journal of Hepatology (2024)
SAT-474 Lesions hyper- to isointense to the surrounding liver in the hepatobiliary phase of gadoxetic acid enhanced MRI
Authors: Alicia Furumaya, Francois Willemssen, Razvan Miclea, Martijn Haring, Robbert de Haas, Shirin Feshtali, Inge Vanhooymissen, Daniel Bos, Robert A. de Man, Jan Ijzermans, Joris Erdmann, Joanne Verheij, Michail Doukas, Otto van Delden, Maarten Thomeer
Journal: Journal of Hepatology (2024)
WED-522-YI Effect of various edible exosomes in restoring gut homeostasis and hepatic metabolic axis: a comparative study
Authors: P. Debishree Subudhi, Jitendra Kumar, Anupama Kumari, Shivani Gautam, Shruti Sureshan, Dinesh Mani Tripathi, Chhagan Bihari, Shiv Kumar Sarin, Sukriti Baweja
Journal: Journal of Hepatology (2024)
WED-558 Inhibition of miR-21 improves muscle activity in experimental metabolic dysfunction-associated steatotic liver disease
Authors: Diogo Fernandes, Mariana Moura Henrique, José Rodrigues, Ana Brígido, Carolina Palma, Laura Izquierdo-Sanchez, Jesus Maria Banales, Pedro Miguel Rodrigues, Rui E. Castro, Andre Simao
Journal: Journal of Hepatology (2024)
SAT-278 FIB-4 score as a predictor of mortality outcomes in individuals with metabolic dysfunction-associated steatotic liver disease with moderate alcohol consumption: a nationwide cohort study
Authors: Majd Aboona, Pojsakorn Danpanichkul, Vincent Chen, Pooja Rangan, Donghee Kim, Naim Alkhouri, Mazen Noureddin, Juan Pablo Arab, Karn Wijarnpreecha
Journal: Journal of Hepatology (2024)
OS-060 Hepatocellular carcinoma development despite histological regression of liver fibrosis following HCV cure (ANRS CirVir, Hepather, LICAVIR)
Authors: Pierre Nahon, Clovis lusivka-Nzinga, Philippe Merle, Fabien Zoulim, Thomas Decaens, Nathalie Ganne-Carrié, Georges-Philippe Pageaux, Vincent Leroy, Laurent Alric, Jean-Pierre Bronowicki, Marc Bourliere, Jérôme Gournay, Albert Tran, Stanislas Pol, Philippe Mathurin, Veronique Loustaud-Ratti, Sophie Metivier, Victor de Lédinghen, Armand Abergel, Dominique Thabut, Louis Dalteroche, Mohamed Bouattour, Tarik Asselah, Denis Ouzan, Paul Cales, Olivier Chazouillères, Moana Gelu-Simeon, Dominique Roulot, Jerome Boursier, Cagnot Carole, Sonia Tamazirt, Alina Pascale, Samuel Nilusmas, Maite Lewin, Marianne Ziol, Fabrice Carrat, Jean-Charles Duclos-Vallée
Journal: Journal of Hepatology (2024)
FRI-046 Alfapump implantation significantly improved quality of life and showed similar safety outcomes compared to a contemporaneously enrolled refractory ascites cohort
Authors: Jasmohan Bajaj, Patrick S. Kamath, K. Rajender Reddy, Puneeta Tandon, Jennifer Lai, Jacqueline O'Leary, Gijs Klarenbeek, Jeroen Capel, Scott Biggins, Hugo Vargas, Guadalupe Garcia-Tsao, Leroy Thacker, Florence Wong
Journal: Journal of Hepatology (2024)
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia
Authors: Marietta Iacucci, Giovanni Santacroce, Snehali Majumder, Jennifer Morael, Irene Zammarchi, Yasuharu Maeda, David Ryan, Antonio Di Sabatino, Maria Rescigno, Maria R Aburto, John F Cryan, Subrata Ghosh
Journal: Gut (2024)

Mounting evidence underscores the pivotal role of the intestinal barrier and its convoluted network with diet and intestinal microbiome in the pathogenesis of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CRC). Moreover, the bidirectional association of the intestinal barrier with the liver and brain, known as the gut-brain axis, plays a crucial role in developing complications, including extraintestinal manifestations of IBD and CRC metastasis. Consequently, barrier healing represents a crucial therapeutic target in these inflammatory-dependent disorders, with barrier assessment predicting disease outcomes, response to therapy and extraintestinal manifestations.New advanced technologies are revolutionising our understanding of the barrier paradigm, enabling the accurate assessment of the intestinal barrier and aiding in unravelling the complexity of the gut-brain axis. Cutting-edge endoscopic imaging techniques, such as ultra-high magnification endocytoscopy and probe-based confocal laser endomicroscopy, are new technologies allowing real-time exploration of the 'cellular' intestinal barrier. Additionally, novel advanced spatial imaging technology platforms, including multispectral imaging, upconversion nanoparticles, digital spatial profiling, optical spectroscopy and mass cytometry, enable a deep and comprehensive assessment of the 'molecular' and 'ultrastructural' barrier. In this promising landscape, artificial intelligence plays a pivotal role in standardising and integrating these novel tools, thereby contributing to barrier assessment and prediction of outcomes.Looking ahead, this integrated and comprehensive approach holds the promise of uncovering new therapeutic targets, breaking the therapeutic ceiling in IBD. Novel molecules, dietary interventions and microbiome modulation strategies aim to restore, reinforce, or modulate the gut-brain axis. These advancements have the potential for transformative and personalised approaches to managing IBD.
Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis
Authors: Jens Thiel, Franziska M Schmidt, Raquel Lorenzetti, Arianna Troilo, Iga Janowska, Lena Nießen, Sophie Pfeiffer, Julian Staniek, Bruno Benassini, Marei-Theresa Bott, Jakov Korzhenevich, Lukas Konstantinidis, Frank Burgbacher, Ann-Katrin Dufner, Natalie Frede, Reinhard E Voll, Jan Stuchly, Marina Bakardjieva, Tomas Kalina, Cristian Roberto Smulski, Nils Venhoff, Marta Rizzi
Journal: Annals of the Rheumatic Diseases (2024)

B-cell depletion time after rituximab (RTX) treatment is prolonged in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) compared with other autoimmune diseases. We investigated central and peripheral B-cell development to identify the causes for the defect in B-cell reconstitution after RTX therapy.
THU-049 Supplemental low-dose hydrocortisone in cirrhotic patients with septic shock: a double-blind, randomised, placebo-controlled, multicentre trial; the SCotCH study
Authors: Philippe Meersseman, María Hernández-Tejero, Juan Manuel Diaz, Joost Wauters, Greet Hermans, Fatima Aziz, Helga Ceunen, Veronica Enith Prado Gonzalez, Mireya Arteaga, Juan Acevedo Haro, Miriam Valdivieso, Cristina Sanchez, Vicente Arroyo, Alexander Wilmer, Javier Fernandez
Journal: Journal of Hepatology (2024)
OS-126 Steatotic liver disease classification is highly dynamic impacting eligibility for clinical trials and subclass-specific interventions
Authors: Katrine Thorhauge, Mads Israelsen, Peter Andersen, Nikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, Helle Schnefeld, Johanne Kragh Hansen, Katrine Tholstrup Bech, Ida Falk Villesen, Katrine Lindvig, Camilla Dalby Hansen, Maja Thiele, Aleksander Krag
Journal: Journal of Hepatology (2024)
WED-082 Multifactorial modulation of the endothelial transcription factor ERG in chronic liver disease
Authors: Sonia Selicean, Eric Felli, Cong Wang, Yeldos Nulan, Horia ştefănescu, Jaime Bosch, Annalisa Berzigotti, Jordi Gracia-Sancho
Journal: Journal of Hepatology (2024)
FRI-112 Rapid infection diagnostics in liver disease- evaluation of a multiplex PCR platform to improve infection and antimicrobial resistance detection
Authors: Veena Ramachandran, Dhaarica Jeyanesan, Merianne Mohammed, Zoe Elliott, Siva Dwarampudi, Marilena Stamouli, Jack Wright, Tasneem Pirani, Vishal C. Patel
Journal: Journal of Hepatology (2024)
LBP-008 AAV8 gene therapy for mitochondrial neurogastrointestinal encephalomyopathy
Authors: Teresa Brevini, Lisa Swift, Helen Reynolds, Richard Stopforth, Yogeshkumar Malam, John Ong, Harry Spiers, Emilija Jovanovic, Miki Scaravaglio, Vitushan Vakeeswarasarma, James Heslop, Sarah Hosgood, Claudia Fuchs, Michael Trauner, Adam Duckworth, Anna Paterson, Arthur Kaser, Jelle van Den Ameele, Vassillis Kosmoliaptsis, Gwilym Webb, Christopher Watson, Andrew Butler, Fotios Sampaziotis
Journal: Journal of Hepatology (2024)
LBP-037 Role of early on-treatment serum hepatitis B virus RNA declines in the prediction of hepatocellular carcinoma risk in patients with chronic hepatitis B
Authors: Shi Liu, Grace Lai-Hung Wong, Rong Fan, Junqi Niu, Hong Ma, Wanying Liang, Xingyu Lu, Jianping Xie, Jia Shang, Dong-Ying Xie, Yali Liu, Bin Zhou, Qing Xie, Jie Peng, Hongbo Gao, Huiying Rao, Jinjun Chen, Jifang Sheng, Sheng Shen, Song Yang, Xiaoguang Dou, Zhengang Zhang, Vincent Wai-Sun Wong, Jinlin Hou, Jian Sun
Journal: Journal of Hepatology (2024)
TOP-097-YI Dynamics of systemic inflammation after TIPS implantation and their impact on acute-on-chronic liver failure and liver-related death
Authors: Andrea Kornfehl, Lukas Hartl, Theresa Mullner-Bucsics, Michael Schwarz, Benedikt Hofer, Nina Dominik, Benedikt Simbrunner, Mathias Jachs, Lukas Reider, Maria Schoder, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Journal: Journal of Hepatology (2024)
LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial
Authors: Paul Brennan, Iain Macpherson, Debbie Troland, Alastair M. Kilpatrick, Thomas Manship, Neil McGowan, John Campbell, Alasdair Fraser, Chloe Pass, Francesca Moroni, David Morris, Alison Glover, Scott Semple, Mark MacMillan, Cat Graham, Marc Turner, John F. Dillon, Neil Lachlan, Jonathan Fallowfield, Stuart J. Forbes
Journal: Journal of Hepatology (2024)
WED-074 The role of endothelial FoxO1 pathway in decompensated liver cirrhosis and acute-on-chronic liver failure
Authors: Fabian Schachteli, Yang Zhang, Sabine Klein, Maximilian Joseph Brol, Robert Schierwagen, Pia Lembeck, Sara Noemi Reinartz Groba, Wenyi Gu, Stefan Zeuzem, Jonel Trebicka, Michael Potente, Frank Erhard Uschner
Journal: Journal of Hepatology (2024)
FRI-093 Clot wave analysis parameters are associated with the severity of liver cirrhosis
Authors: Kessarin Thanapirom, Pisit Tangkijvanich, Sirinporn Suksawatamnuay, Panarat Thaimai, Prooksa Ananchuensook, Pitiphong Kijrattanakul, Sombat Treeprasertsuk, Pantep Angchaisuksiri, Piyawat Komolmit
Journal: Journal of Hepatology (2024)
THU-390 Achieving HCV elimination in underserved populations-an austrian initiative for HCV care for homeless people without medical insurance
Authors: Caroline Schwarz, Bernadette Becsi, Stephan Leick, Stephan Gremmel, Lena Wien, Enisa Gutic, Thomas Reiberger, Hans Haltmayer, Michael Gschwantler
Journal: Journal of Hepatology (2024)
THU-374 Description of age, sex, and characteristics of hepatitis C patients in the SVR10 K study: a real-world SOF/VEL analysis performed across five global regions
Authors: Soo Aleman, Fatima Higuera-de-la-Tijera, Francisco Javier Garcia-Samaniego, Marta Casado-Martin, Grace Lai-Hung Wong, Mohammed Alzaabi, Habiba Kamal, Karin Lindahl, Aastha Chandak, Marta Martinez, Artak Khachatryan, Linda Chen, Candido Hernández, Kim Vanstraelen, Ming-Lung Yu
Journal: Journal of Hepatology (2024)
OS-023-YI Liver transplantation due to biliary tract dysplasia in primary sclerosing cholangitis
Authors: Sigurd Breder, Christina Villard, Emma Eide, Benny Wang, Lise Engesæter, Henrik Mikael Reims, Johannes R. Hov, Espen Melum, Lars Aabakken, Pål Dag Line, Kristine Wiencke, Annika Bergquist, Trine Folseraas
Journal: Journal of Hepatology (2024)
THU-373-YI Quality of etiotropic therapy efficasy of chronic hepatitis C patients in accordance of toll-like receceptor 4 +3725G/C gene polymorfisms variety
Authors: Tetiana Bevz, Larysa Moroz, Kiarina Myroniuk-Konstantynovych, Iryna Bondaruk, Galyna Martyniuk, Yaroslav Demchyshyn
Journal: Journal of Hepatology (2024)
THU-379 Artificial intelligence model for predicting liver-related events in non-cirrhotic patients after successful treatment by direct-acting antivirals for chronic hepatitis C
Authors: Huapeng Lin, Jimmy Che-To Lai, Hye Won Lee, Terry Cheuk-Fung Yip, Sang Hoon Ahn, Grace Lai-Hung Wong, Xiangjun Meng, Vincent Wai-Sun Wong, Victor de Lédinghen, Seung Up Kim
Journal: Journal of Hepatology (2024)
OS-031 Imdusiran (AB-729) administered every 8 weeks for 24 weeks followed by the immunotherapeutic VTP-300 maintains lower HBV surface antigen levels in NA-suppressed CHB subjects than 24 weeks of imdusiran alone
Authors: Kosh Agarwal, Man-Fung Yuen, Stuart Roberts, Gin-Ho Lo, Chao-Wei Hsu, Wan-Long Chuang, Chi-Yi Chen, Pei-Yuan Su, Sam Galhenage, Sheng-Shun Yang, Emily P. Thi, Katie Anderson, Deana Antoniello, Elina Medvedeva, Timothy Eley, Tilly Varughese, Louise Bussey, Charlotte Davis, Antonella Vardeu, Christine L. Espiritu, Sharie C Ganchua, Christina Iott, Elizabeth Eill, Tom Evans, Karen D Sims
Journal: Journal of Hepatology (2024)
THU-389 Sustained virological response after early discontinuation of HCV treatment
Authors: Robert Flisiak, Dorota Zarębska-Michaluk, Ewa Janczewska, Anna Parfieniuk-Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha-Litwin, Rafal Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala-Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz
Journal: Journal of Hepatology (2024)
WED-379 Intrahepatic changes in immunologic and virologic markers during siRNA JNJ-73763989 (JNJ-3989) based treatment of chronic hepatitis B (CHB) patients: imaging mass cytometry (IMC) analyses from the INSIGHT study
Authors: Kim Thys, Marjolein Crabbe, Hans Wils, Hinrich Goehlmann, Simon Verheijden, Pietro Lampertico, Tarik Asselah, Edward J. Gane, Scott K. Fung, Patrick Kennedy, Thomas Vanwolleghem, Ewa Janczewska, Julian Schulze zur Wiesch, Mark S. Sulkowski, Carine Guinard-Azadian, Michael Biermer, Oliver Lenz
Journal: Journal of Hepatology (2024)
Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance
Authors: Yumeng Wang, Chengxi Li, Jianping Li, Shu Zhang, Qinyu Zhang, Jinao Duan, Jianming Guo
Journal: Acta Pharmaceutica Sinica B (2024)

The intestinal mucus barrier is an important line of defense against gut pathogens. Damage to this barrier brings bacteria into close contact with the epithelium, leading to intestinal inflammation. Therefore, its restoration is a promising strategy for alleviating intestinal inflammation. This study showed that
WED-367 Viral sequence analysis of chronic hepatitis B (CHB) patients treated with the silencing RNA (siRNA) JNJ-3989 in the REEF-1 and REEF-2 clinical studies
Authors: Thierry Verbinnen, Erkki Lathouwers, John Jerzorwski, Michael Biermer, Craig Grant, Kosh Agarwal, Man-Fung Yuen, Sandra De Meyer, Oliver Lenz
Journal: Journal of Hepatology (2024)
WED-412 Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update
Authors: Chong Zhang, Dawu Zeng, Dachuan Cai, Xiulan Xue, Lingyi Zhang, Baojun Song, Yufeng Gao, Yan Huang, Jia Shang, Xiaofeng Wu, Ying Zhang, Hua Jin, Hui Chen, Hong Tang, Xiaobo Lu, Yujuan Guan, Feng Min, Liang Xu, Gang Li, Zhenguang Wang, Xiaoguang Dou
Journal: Journal of Hepatology (2024)
WED-366 Characterization of BJT-778, an anti-HBsAg neutralizing monoclonal antibody for treatment of hepatitis B virus and hepatitis D virus infections
Authors: Hilario Ramos, Ronald Alcala, Maud Michelet, Emmanuel Combe, Jerome Deval, Roy Grecko, Kevin Lin, Nancy Shulman, Fabien Zoulim, Keting Chu, Barbara Testoni, Hassan Javanbakht
Journal: Journal of Hepatology (2024)
WED-372 Downregulation of soluble FASLG as a potential mechanism of enhanced immune-related clearance of infected hepatocytes induced by JNJ-73763989 in HBeAg-negative virologically suppressed chronic hepatitis B patients
Authors: Simon Verheijden, Marianne Tuefferd, Marjolein Crabbe, Ewoud de Troyer, Thomas Vanwolleghem, Harry Janssen, Michael Biermer, Oliver Lenz
Journal: Journal of Hepatology (2024)
WED-381 A double-blind, placebo-controlled, single-ascending dose phase I a study to evaluate the safety, tolerability, and pharmacokinetics of HT-102, a neutralizing antibodies against the hepatitis B surface antigen in Chinese healthy volunteers
Authors: Mingjian Zhang, Dong Wang, Shanzhong Zhang, Yanqin Ma, Lijuan Ding, Zhipeng Zhang, Lungen Lu, Xueying Ding
Journal: Journal of Hepatology (2024)
TOP-385-YI Evaluation of liver fibrosis in patients with advanced chronic liver disease due to hcv after 6 years of sustained viral response. study with paired biopsies at 3 and 6 years
Authors: Lidia Canillas, Dolores Naranjo, Teresa Broquetas, Zoe Mariño, Xavier Forns, Jose A. Carrión
Journal: Journal of Hepatology (2024)
FRI-373 Impact of pregnancy on global and HBV-specific B-cell immunity
Authors: Anna Pocurull, Mirea García-López, Cristina Collazos, Thais Leonel, Marta López, Simon Fletcher, Elena Perpinan, Georgios Koutsoudakis, Patricia Huelin, Carlos Aracil, Juan Carlos Hurtado, Xavier Forns, Mala Maini, Sofía Pérez-del-Pulgar, Sabela Lens
Journal: Journal of Hepatology (2024)
SAT-409 Whole-genome hepatitis B virus sequencing at low viral loads from serum and dried blood spot using a multiplexed tiled amplicon approach
Authors: Sheila Lumley, Christopher Kent, Samuel Wilkinson, Camille Morgan, Elizabeth Waddilove, Marion Delphin, George Airey, James Campbell, Catherine De Lara, Jacqueline Martin, Patrick Ngimbi, Jonathan B. Parr, Peyton Thompson, Eleanor Barnes, Azim Ansari, Nick Loman, Josh Quick, Philippa C Matthews
Journal: Journal of Hepatology (2024)
FRI-444 An initial study of geospatial approach for molecular epidemiology of hepatitis B virus in Indonesia: tale from two regions
Authors: Sri Jayanti, Turyadi Turyadi, Nu'man AS Daud, AM Luthfi Parewangi, Rini Rachmawarni Bachtiar, Irda Handayani, Rina Masadah, Agustiningsih Agustiningsih, Korri Elvanita El Khobar, Muhammad Nasrum Massi, David Handojo Muljono, Caecilia Sukowati
Journal: Journal of Hepatology (2024)
WED-411 The large (LHBs) and middle (MHBs) hepatitis B surface antigen are associated with response to bulevirtide or PEG-IFNa treatment in patients with chronic hepatitis Delta (CHD)
Authors: Maria Pfefferkorn, Jonathan Seltmann, Romy Winkler, Rodrigue Kamga Wouambo, Sara Sopena Santisteve, Madlen Matz-Soja, Maria Buti, Heyne Renate, Pietro Lampertico, Thomas Berg, Florian van Bommel
Journal: Journal of Hepatology (2024)
SAT-383 Rapid analysis of HBV-specific T cell secretomes reveals distinct antiviral immune profiles among chronic HBV patients
Authors: Nina Le Bert, Apostolos Koffas, Anthony Tan, Rajneesh Kumar, Lung-Yi Mak, Tizong Miao, Yu Lei, Smrithi Hariharaputran, Shou Kit Hang, Yifei Guo, Qi Chen, Upkar Gill, Wan Cheng Chow, Antonio Bertoletti, Patrick Kennedy
Journal: Journal of Hepatology (2024)
FRI-407 Screening rates, prevalence, and natural history of hepatitis B/ delta virus co-infection vs. hepatitis B mono-infection: data from a large US integrated healthcare system
Authors: Varun Saxena, Lue-Yen Tucker, Xiaoran Li, Krisna Chai, Suk Seo, Nizar Mukhtar, Grace M. Chee, Kyung Min Kwon, Sreepriya Balasubramanian, Brock Macdonald, Julie Schmittdiel
Journal: Journal of Hepatology (2024)
FRI-408 Statins in untreated chronic HBV link with improved survival, liver outcome and inflammation: a large multicenter retrospective real-world cohort study
Authors: Mohammed Suki, Tamer Safadi, Yael Milgrom, Mohamad Masarowah, Wadiaa Hazo, Yariv Tiram, Johnny Amer, Abed Khakayla, Ashraf Imam, Esther Forkosh, Joseph Sackran, Ofer Perzon, Ahmad Salhab, Sylvia Drazilova, Peter Jarčuška, Rifaat Safadi
Journal: Journal of Hepatology (2024)
FRI-425 Hepatitis B core-related antigen (HBcrAg) in a prospective French hospital database on chronic hepatitis B (HBVbiomark)
Authors: Erwan Vo Quang, Stéphane Chevaliez, Scoazec Giovanna, Varaut Anne, Giuliana Amaddeo, Amal Boukraa, Mélanie Simoes, Anne Laure Mazialivoua, Alexandre Soulier, Valérie Ortonne, Olivia Garrigou, Jean-Michel Pawlotsky, Vincent Leroy, Patrick Ingiliz
Journal: Journal of Hepatology (2024)
WED-396 Changes in metabolic parameters after switching from tenofovir disoproxil fumarate to tenofovir alafenamide among chronic hepatitis B patients: a randomized, open-label controlled trial
Authors: Titinan Veerachit-O-larn, Thanapat Atthakitmongkol, Wanwarang Teerasamit, Supot Nimanong, Siwaporn Chainuvati, Phunchai Charatcharoenwitthaya, Tawesak Tanwandee, Watcharasak Chotiyaputta
Journal: Journal of Hepatology (2024)
FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Authors: Moon Haeng Hur, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Youngsu Park, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
Journal: Journal of Hepatology (2024)
FRI-363-YI Association between metabolic dysfunction, severity of liver fibrosis and fibrosis progression in patients with chronic hepatitis B-an individual patient data meta-analysis
Authors: Lisa M. van Velsen, Lesley A. Patmore, Jordan J. Feld, Henry L.Y. Chan, Teerha Piratvisuth, Rong-Nan Chien, Edo J. Dongelmans, Vedran Pavlovic, Leland J. Yee, Willem Pieter Brouwer, Audrey H. Lau, Bettina E. Hansen, Maria Buti, Qing Xie, Keyur Patel, Scott K. Fung, Harry L.A. Janssen, Milan J. Sonneveld
Journal: Journal of Hepatology (2024)
WED-393 Association between post-treatment ALT elevation and subsequent hepatitis B surface antigen seroclearance in chronic hepatitis B patients stopping nucleos (t)ide analogue therapy
Authors: Yao-Chun (Holden) Hsu, Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, Yi-Ling Wu, Shang-Chen Tseng, Chih-Lung Hung, Jaw-Town Lin
Journal: Journal of Hepatology (2024)